Among the several subgroups of patients, levels of different biomarkers, including DNTs and sCD95L, were observed significantly higher in the ALPS-FAS patients than in the “unknown ALPS” (ALPS-U), cases for which the genetic determinant is not identified. The gene discussed is FAS; the disease is autoimmune lymphoproliferative syndrome.